haloperidol has been researched along with Polycystic Ovarian Syndrome in 1 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ten normoprolactinemic and 10 hyperprolactinemic patients, all with polycystic ovary syndrome (PCO), were subjected to prolactin (PRL) stimulatory tests with thyrotropin-releasing hormone (TRH), 200 microgram intravenously, and haloperidol (a dopamine-blocking agent), 1 mg intramuscularly." | 3.66 | Prolactin release in polycystic ovary. ( del Pozo, E; Falaschi, P; Frajese, G; Petrangeli, E; Pompei, P; Rocco, A; Toscano, V, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Falaschi, P | 1 |
| del Pozo, E | 1 |
| Rocco, A | 1 |
| Toscano, V | 1 |
| Petrangeli, E | 1 |
| Pompei, P | 1 |
| Frajese, G | 1 |
1 other study available for haloperidol and Polycystic Ovarian Syndrome
| Article | Year |
|---|---|
Prolactin release in polycystic ovary.
Topics: Estrogens; Female; Follicle Stimulating Hormone; Haloperidol; Humans; Luteinizing Hormone; Polycysti | 1980 |